• Adams, M. (1959). Bacteriophages, New York: Interscience Publishers.
  • Andersson, P., Engberg, I., Lidin-Janson, G., Lincoln, K., Hull, R., Hull, S. and Svanborg, C. (1991) Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 59, 29152921.
  • Capparelli, R., Nocerino, N., Iannaccone, M., Ercolini, D., Parlato, M., Chiara, M. and Iannelli, D. (2010) Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J Infect Dis 201, 5261.
  • Chibeu, A., Ceyssens, P.J., Hertveldt, K., Volckaert, G., Cornelis, P., Matthijs, S. and Lavigne, R. (2009) The adsorption of Pseudomonas aeruginosa bacteriophage phiKMV is dependent on expression regulation of type IV pili genes. FEMS Microbiol Lett 296, 210218.
  • Donlan, R.M. (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17, 6672.
  • Donlan, R.M. and Costerton, J.W. (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167193.
  • Fu, W., Forster, T., Mayer, O., Curtin, J.J., Lehman, S.M. and Donlan, R.M. (2010) Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54, 397404.
  • Giamarellou, H. and Poulakou, G. (2009) Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 69, 18791901.
  • Harcombe, W.R. and Bull, J.J. (2005) Impact of phages on two-species bacterial communities. Appl Environ Microbiol 71, 52545259.
  • Hidron, A.I., Edwards, J.R., Patel, J., Horan, T.C., Sievert, D.M., Pollock, D.A. and Fridkin, S.K. (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29, 9961011.
  • Hull, R.A., Donovan, W.H., Del Terzo, M., Stewart, C., Rogers, M. and Darouiche, R.O. (2002) Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun 70, 64816484.
  • Kay, M.K., Erwin, T.C., Mclean, R.J. and Aron, G.M. (2011) Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communities. Appl Environ Microbiol 77, 821829.
  • Kutter, E. and Sulakvelidze, A. (eds.) (2005) Bacteriophages: Biology and Applications. Boca Raton, FL: CRC Press.
  • Labrie, S.J., Samson, J.E. and Moineau, S. (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8, 317327.
  • Lenski, R. and Levin, B. (1985) Constaints on the coevolution of bacteria and virulent phage–a model, some experiments, and predictions for natural communities. Am Nat 125, 585602.
  • Maki, D. and Tambyah, P. (2001) Engineering out the risk of infection with urinary catheters. Emerg Infect Dis 7, 113.
  • McGowan, J.E. Jr (2006) Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med 119, S29S36; discussion S62–70.
  • Mizoguchi, K., Morita, M., Fischer, C.R., Yoichi, M., Tanji, Y. and Unno, H. (2003) Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl Environ Microbiol 69, 170176.
  • O'toole, G.A. and Kolter, R. (1998) Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 30, 295304.
  • Prasad, A., Cevallos, M.E., Riosa, S., Darouiche, R.O. and Trautner, B.W. (2009) A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization. Spinal Cord 47, 565569.
  • Trautner, B.W. and Darouiche, R.O. (2002) Prevention of urinary tract infection in patients with spinal cord injury. J Spinal Cord Med 25, 277283.
  • Trautner, B.W., Darouiche, R.O., Hull, R.A. and Thornby, J.I. (2002) Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. J Urol 167, 375379.
  • Trautner, B.W., Hull, R.A. and Darouiche, R.O. (2003) Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 61, 10591062.
  • Trautner, B.W., Hull, R.A. and Darouiche, R.O. (2005) Prevention of catheter-associated urinary tract infection. Curr Opin Infect Dis 18, 3741.
  • Trautner, B.W., Hull, R.A., Thornby, J.I. and Darouiche, R. (2007) Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymp-tomatic colonization. Infect Control Hosp Epidemiol 28, 9294.
  • Trautner, B.W., Cevallos, M.E., Li, H., Riosa, S., Hull, R.A., Hull, S.I., Tweardy, D.J. and Darouiche, R.O. (2008) Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference. J Infect Dis 198, 899906.